GlassScriptPhysician profile
Amy L Kasper
NPI 1902534514
$2,397.01
in general payments reported to CMS, 2019-2025
17 companies · $1,484 in 2025
The $1,484 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $246 · 2023: $407 · 2024: $260 · 2025: $1,484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357 · Travel and Lodging: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.38 |
| Travel and Lodging | $793.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,338.93 | 2022-2025 | Watchman, Watchman Flx, Farapulse |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.34 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $161.13 | 2023-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $120.04 | 2022-2025 | Farxiga, Andexxa |
| Sanofi-Aventis U.S. LLC | $92.22 | 2022-2023 | |
| Pfizer INC. | $76.33 | 2024-2025 | |
| Heartflow, INC. | $64.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.71 | 2022-2025 | |
| Amgen INC. | $50.03 | 2023-2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $36.59 | 2025 | Attruby |
| Scpharmaceuticals INC. | $33.81 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $33.10 | 2023-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $28.32 | 2023-2025 | |
| Atricure, INC. | $24.66 | 2024 | |
| Cvrx, INC. | $18.56 | 2023 | Barostim Neo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.36 | 2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $13.48 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Kasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.